Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 19;24(1):498.
doi: 10.1186/s12885-024-12099-8.

Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review

Kerrie Curtis  1   2   3 , Karla Gough  4   5   6 , Meinir Krishnasamy  4   5   6   7 , Elena Tarasenko  8 , Geoff Hill  9 , Samantha Keogh  10
Affiliations

Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review

Kerrie Curtis et al. BMC Cancer. .

Abstract

Background: Lack of agreed terminology and definitions in healthcare compromises communication, patient safety, optimal management of adverse events, and research progress. The purpose of this scoping review was to understand the terminologies used to describe central venous access devices (CVADs), associated complications and reasons for premature removal in people undergoing cancer treatment. It also sought to identify the definitional sources for complications and premature removal reasons. The objective was to map language and descriptions used and to explore opportunities for standardisation.

Methods: A systematic search of MedLine, PubMed, Cochrane, CINAHL Complete and Embase databases was performed. Eligibility criteria included, but were not limited to, adult patients with cancer, and studies published between 2017 and 2022. Articles were screened and data extracted in Covidence. Data charting included study characteristics and detailed information on CVADs including terminologies and definitional sources for complications and premature removal reasons. Descriptive statistics, tables and bar graphs were used to summarise charted data.

Results: From a total of 2363 potentially eligible studies, 292 were included in the review. Most were observational studies (n = 174/60%). A total of 213 unique descriptors were used to refer to CVADs, with all reasons for premature CVAD removal defined in 84 (44%) of the 193 studies only, and complications defined in 56 (57%) of the 292 studies. Where available, definitions were author-derived and/or from national resources and/or other published studies.

Conclusion: Substantial variation in CVAD terminology and a lack of standard definitions for associated complications and premature removal reasons was identified. This scoping review demonstrates the need to standardise CVAD nomenclature to enhance communication between healthcare professionals as patients undergoing cancer treatment transition between acute and long-term care, to enhance patient safety and rigor of research protocols, and improve the capacity for data sharing.

Keywords: Catheters indwelling; Central venous access device; Central venous catheters; Complication; Device removal; Premature removal; Terminology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
PRISMA flow diagram
Fig. 2
Fig. 2
Definitional sources for premature CVA removal where provided
Fig. 3
Fig. 3
Definitional sources for CVAD complications where provided
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Zakhour R, Chaftari AM, Raad II. Catheter-related infections in patients with haematological malignancies: novel preventive and therapeutic strategies. Lancet Infect Dis. 2016;16(11):e241–e250. doi: 10.1016/S1473-3099(16)30213-4. - DOI - PubMed
    1. Moss JG, Wu O, Bodenham AR, Agarwal R, Menne TF, Jones BL, et al. Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial. Lancet. 2021;398(10298):403–415. doi: 10.1016/S0140-6736(21)00766-2. - DOI - PubMed
    1. Mariggiò E, Iori AP, Micozzi A, Chistolini A, Latagliata R, Berneschi P, et al. Peripherally inserted central catheters in allogeneic hematopoietic stem cell transplant recipients. Support Care Cancer. 2020;28(9):4193–4199. doi: 10.1007/s00520-019-05269-z. - DOI - PubMed
    1. Levi M, Sivapalaratnam S. An overview of thrombotic complications of old and new anticancer drugs. Thromb Res. 2020;191 Suppl 1:S17–21. doi: 10.1016/S0049-3848(20)30391-1. - DOI - PubMed
    1. van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, et al. Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol. 2015;33(17):1918–1927. doi: 10.1200/JCO.2014.59.1081. - DOI - PubMed

Publication types

MeSH terms